Partially randomised, patient preference trials for inflammatory bowel disease

被引：0
|
作者：
Noor, Nurulamin M. [1 ,2 ]
Siegel, Corey [3 ,4 ]
机构：
[1] Cambridge Univ Hosp NHS Fdn Trust, Dept Gastroenterol, Addenbrookes Hosp, Cambridge CB2 0QQ, England
[2] UCL, Res Council Clin Trials Unit, London, England
[3] Dartmouth Hitchcock Med Ctr, Sect Gastroenterol & Hepatol, Inflammatory Bowel Dis Ctr, Lebanon, NH USA
[4] Geisel Sch Med, Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA
来源：
LANCET GASTROENTEROLOGY & HEPATOLOGY | 2022年 / 7卷 / 11期
关键词：
CROHNS-DISEASE;
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：981 / 983
页数：3
相关论文
共 50 条
  • [1] Partially randomised patient preference trials
    Brocklehurst, P
    BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (12): : 1332 - 1335
  • [2] The statistical pitfalls of partially randomised patient preference trials
    Gemmell, I.
    Dunn, G.
    JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2008, 62 : A25 - A25
  • [3] Partially randomised patient preference trials as an alternative design to randomised controlled trials: systematic review and meta-analyses
    Wasmann, Karin A.
    Wijsman, Pieta
    van Dieren, Susan
    Bemelman, Willem
    Buskens, Christianne
    BMJ OPEN, 2019, 9 (10):
  • [4] Power Calculations in Randomised Controlled Trials of Inflammatory Bowel Disease
    Rogerio, Parra
    Marley, Feitosa
    Sandro, Ferreira
    Hugo, Camargo
    joaquim, Rocha Jose
    Omar, Eres
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S15 - S15
  • [5] DEVELOPING TREATMENT ATTRIBUTES FOR A PATIENT PREFERENCE SURVEY IN INFLAMMATORY BOWEL DISEASE
    Schoefs, E.
    Vermeire, S.
    Ferrante, M.
    Sabino, J.
    Verstockt, B.
    Avedano, L.
    Haaf, I
    De Rocchis, M. S.
    Broggi, A.
    Sajak-Szczerba, M.
    Saldana, R.
    Huys, I
    Janssens, R.
    VALUE IN HEALTH, 2022, 25 (12) : S434 - S434
  • [6] Quality of reporting inflammatory bowel disease randomised controlled trials: a systematic review
    Gordon, Morris
    Khudr, Jamal
    Sinopoulou, Vassiliki
    Lakunina, Svetlana
    Rane, Aditi
    Akobeng, Anthony
    BMJ OPEN GASTROENTEROLOGY, 2024, 11 (01):
  • [7] Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study): protocol for a partially randomised patient preference trial
    Bouhuys, Marleen
    Lexmond, Willem S.
    Dijkstra, Gerard
    Lobaton, Triana
    Louis, Edouard
    van Biervliet, Stephanie
    Groen, Henk
    Guardiola, Jordi
    van Rheenen, Patrick
    BMJ OPEN, 2021, 11 (11):
  • [8] Patient preference randomised controlled trials in mental health research
    Howard, L
    Thornicroft, G
    BRITISH JOURNAL OF PSYCHIATRY, 2006, 188 : 303 - 304
  • [9] Are We Ready to Abandon Placebo in Randomised Clinical Trials for Inflammatory Bowel Disease? Pros and Cons
    Danese, Silvio
    Schabel, Elmer
    Masure, Johan
    Plevy, Scott
    Schreiber, Stefan
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S548 - S552
  • [10] Review: randomised controlled trials in inflammatory bowel disease-common challenges and potential solutions
    Schreiber, Stefan
    Irving, Peter M.
    Sharara, Ala, I
    Dolores Martin-Arranz, Maria
    Hebuterne, Xavier
    Penchev, Plamen
    Danese, Silvio
    Anthopoulos, Prodromos
    Akhundova-Unadkat, Gamar
    Baert, Filip
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (06) : 658 - 669
12345